リウマチエコー.indd
|
|
|
- ゆきさ さかど
- 6 years ago
- Views:
Transcription
1 GE Healthcare RA RA X MRI
2 1. RA OMERACT Outcome Measures in Rheumatoid Arthritis Clinical Trial [1] : P Fat Femur Fat P Fat : Femur Rad Lun Cap Rad : Lun Cap R A 2
3 2. RA 1 RA RA RA RA [2] RA 1. RA RA RA ACR 68 DAS 44 DAS28 28 PIP /P / / / / MTP [3] 4. PIP RA RA 3
4 5. RA ACR RA X 2009 ACR/EULAR RA RA [4-6] [2] RA OA 6. RA GE LOGIQ : CRP 0.4 mg/dl, RF < 5 U/L, CCP 79 U/mL X PIP P RA ACR ACR/EULAR RA 2 PIP 3 PIP P 3 P 5 NSAID 2 5 CRP 2.3 mg/dl RA MTX 2 2 RA RA * MP 4 MP MP 3 P 2 PIP 3 PIP
![7. RA RA DAS [7] RA RA [8-10] DAS28 GE Venue 40 6 6. Venue 40 Musculoskeletal 8.](/docs-images/80/80729390/images/5-0.jpg "RA GE LOGIQ7 RA 65 7 RA 2 MTX 8 mg/week DAS28 Steinbrocker Stage III/ Class II RF / CCP 2 DAS28 PIP 7 : CRP 0.")
5 7. RA RA DAS [7] RA RA [8-10] DAS28 GE Venue Venue 40 Musculoskeletal 8. RA GE LOGIQ7 RA 65 7 RA 2 MTX 8 mg/week DAS28 Steinbrocker Stage III/ Class II RF / CCP 2 DAS28 PIP 7 : CRP 0.3 mg/dl, RF < 5 U/L VAS 93 mm DAS28- CRP 7.02 PIP PIP RA 8 RA DAS28 RA
6 8. 2 * MP Deltoid H 5 PIP 2 P Scapula Deltoid H Femur MP Deltoid Scapula H Femur Tibia : Tibia 9. MRI MRI 2 ADL / / / 2. MRI MRI MRI MRI 6
7 10. RA 2 3 X RA X 1. Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M, D'Agostino MA, Sanchez EN, Iagnocco A, Schmidt WA, Bruyn GA, Kane D, O'Connor PJ, Manger B, Joshua F, Koski J, Grassi W, Lassere MN, Swen N, Kainberger F, Klauser A, Ostergaard M, Brown AK, Machold KP, Conaghan PG; OMERACT 7 Special Interest Group. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol Dec;32(12): Wakefield RJ, Gibbon WW, Conaghan PG, O'Connor P, McGonagle D, Pease C, Green MJ, Veale DJ, Isaacs JD, Emery P. The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography. Arthritis Rheum Dec;43(12): Monthly Book Orthopaedics 2010 May;23(6): Kane D, Balint PV, Sturrock RD. Ultrasonography is superior to clinical examination in the detection and localization of knee joint effusion in rheumatoid arthritis. J Rheumatol May;30(5): Wakefield RJ, Green MJ, Marzo-Ortega H, Conaghan PG, Gibbon WW, McGonagle D, Proudman S, Emery P. Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease. Ann Rheum Dis Apr;63(4): Naredo E, Bonilla G, Gamero F, Uson J, Carmona L, Laffon A. Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography. Ann Rheum Dis Mar;64(3): Thompson PW, Hart LE, Goldsmith CH, Spector TD, Bell MJ, Ramsden MF. Comparison of four articular indices for use in clinical trials in rheumatoid arthritis: patient, order and observer variation. J Rheumatol 1991;18: Backhaus M, Ohrndorf S, Kellner H, Strunk J, Backhaus TM, Hartung W, Sattler H, Albrecht K, Kaufmann J, Becker K, Sörensen H, Meier L, Burmester GR, Schmidt WA. Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project. Arthritis Rheum Sep 15;61(9): Naredo E, Rodríguez M, Campos C, Rodríguez-Heredia JM, Medina JA, Giner E, Martínez O, Toyos FJ, Ruíz T, Ros I, Pujol M, Miquel X, García L, Aznar JJ, Chamizo E, Páez M, Morales P, Rueda A, Tuneu R, Corominas H, de Agustín JJ, Moragues C, Mínguez D, Willisch A, González- Cruz I, Aragón A, Iglesias G, Armas C, Pablo Valdazo J, Vargas C, Calvo-Alén J, Juan-Mas A, Salvador G, Puigdollers A, Galíndez E, Garrido N, Salaberri J, Raya E, Salles M, Díaz C, Cuadra JL, Garrido J; Ultrasound Group of The Spanish Society of Rheumatology. Validity, reproducibility, and responsiveness of a twelve-joint simplified power doppler ultrasonographic assessment of joint inflammation in rheumatoid arthritis. Arthritis Rheum Apr 15;59(4): Dougados M, Jousse-Joulin S, Mistretta F, D'Agostino MA, Backhaus M, Bentin J, Chales G, Chary-Valckenaere I, Conaghan PG, Etchepare F, Gaudin P, Grassi W, van der Heijde D, Sellam J, Naredo E, Szkudlarek M, Wakefield R, Saraux A. Evaluation of several ultrasonography scoring systems of synovitis and comparison to clinical examination: Results from a prospective multi-center study of rheumatoid arthritis.ann Rheum Dis Sep 9. [Epub ahead of print] 7
8 使用者の経験に基づく記載であり GE ヘルスケア ジャパン株式会社が 仕様値として保証するものではありません GE WEB LOGIQ BZZ Venue ABBZX Venue 40 Musculoskeletal Musculoskeletal GEヘルスケア ジャパン株式会社 Rev.1.0 0J AK-C1(KM) Printed in Japan CI D42A1-2 JB36892JA
cra28-1.7
臨床リウマチ,28: 7~15,2016 7 総説 関節エコー画像診断の進歩 Key words: rheumatoid arthritis, musculoskeletal ultrasonography, guidelines for musculoskeletal ultrasonography, classification criteria for rheumatoid arthritis,
期待されている 1) この生物学的製剤の登場により RAの治療は 疼痛や腫脹の緩和による ADLの維持から 寛解 治癒へと標的が大きく変化してきている 2) 治療方針も変化し 早い段階から強い治療を受けることにより 寛解が実現できるという報告が多くなされている 当院ではリウマチ患者の約 25% に生
論文 関節エコーを臨床へ生かすために リウマチ診療における関節エコー検査 For Applying Joint Ultrasonography to Clinical Medicine Joint Ultrasonography Examinations in Rheumatoid Arthritis Treatment 谷村一秀 1) Kazuhide Tanimura 北野明美 2) Akemi
研究成果報告書(基金分)
RA RF ACPA RA RA RA RA RA IC IC RA RA IC RA IC RA IC RA RA RA IC 1 RA OA RA RA OA WinROOF RT-PCR ELISA RA RA RA OA 1 2 Thrombospondin-1 TSP-1 Platelet factor 4 PF-4RA RA RA RA 2 2 TSP-1 TSP-1 SS SLE RF
さ すなわち小関節に好発する多関節炎 自己抗体陽性 炎症反応上昇 そして持続性病態を良く反映したものとなった ( 図 1) 4)5) しかしながらその有用性の検証では MTX 必要性予測の精度が検証コホートにより必ずしも高くないことが示され (ROC 解析の AUC; ) 臨床評価に
論文 筋骨格超音波による関節リウマチ診断の精度の向上 Musculoskeletal Ultrasound Improves the Accuracy of Diagnosis of Rheumatoid Arthritis 池田 啓 Kei Ikeda 中込大樹 Daiki Nakagomi 中島 裕史 Hiroshi Nakajima 千葉大学医学部附属病院アレルギー 膠原病内科 2010 年
untitled
1-92009 X 22 RA 2009ACR/EULAR MTX 3 TNF 3 IL-6 1 MTX RA Key words rheumatoid arthritisra 2009RA criteria 2009 biologicstnf anti-tnf drugsremission I rheumatoid arthritisra X 1 1 2 II 629-0392 TEL0771-72-1181FAX0771-72-0326
untitled
2007726 JICA 1... 1 2... 1 2.1... 1 2.2... 1 2.3... 2 2.4... 2 2.5... 2 2.6... 5 2.7... 5 2.8... 6 3... 8 3.1... 8 3.1.1 200720073... 8 3.1.2 2007420083... 12 3.1.3 2008420093... 20 3.1.4 20094200911...
リウマチ対策(H17～)の評価 と現在の問題点
リウマチ対策 (H17~) の評価 と現在の問題点 東京医科歯科大学膠原病 リウマチ内科 日本リウマチ学会理事長 宮坂信之 評価法 (5 点法 ) 評価対象 : リウマチに関する予防 治療法を確立し 国民の安心 安全な生活の実現に寄与 貢献をしたか? 5: 大いにした 4: した 3: どちらでもない 2: していない 1: 全くしていない リウマチ対策 (H17~H21) (1) 医療等の提供 (
1. Crellin QR, Maccabe JJ and Hamilton EBD: Severe subluxation of the cervical spine in rheumatoid arthritis. J Bone Joint Surg (1970) 52-B, 224-250. 2. Webb FWS, Hickman JA and Brew DStJ: Death from vertebral
審査報告書（案）
19 83 7 18 628 1 19 8 3 7 18 6 28 30 MI 31 360 21700BZY00247000 5mm CEA 59 mm 2 50% 80 1. 2. 3 19 8 3 [ ] 7 [ ] [ ] [ ] [ ] 18 6 28 [ ] CEA 49mm 50 80 2 4 carotid endarterectomy CEA 1,2 CEA ECST 3 NASCET
SLActive_cs4.indd
SIMPLY BETTER STRAUMANN SLActive SLActive 1 SLActive SLA SLActive SLA 2,3,4,5,6,7 SLActive 1,3,4,5,6,7,8,9 3 4 2 8 SLActive SLA SLActive SLA 1 2 3 4 5 6 7 8 1,2 SLActive 2 2 4 1 SLActive SLA SLActive 11
E Societe de Pathologie Infectieuse de Langue Francaise (, 1991) E Spanish Thoracic Society (1992) E American Thoracic Society (ATS : 1993. ü ù2001 ) E British Thoracic Society (1993, ü è2001 ) E Canadian
_2009MAR.ren
ISSN 0389-5254 2009 No.2 MAR JAPAN AIRCRAFT PILOT ASSOCIATION C O N T E N T S No.313 2009 No.2 MAR é 2009 MAR 2009 MAR 2009 MAR 2009 MAR 2009 MAR 2009 MAR 2009 MAR 2009 MAR 2009 MAR 2009 MAR 2009 MAR
mrna Zc3h12a IL-6
mrna Zc3h12a IL-6 IgG4 The 4th East Asian Group of Rheumatology (EAGOR2011) S3PE CaMK EBM PubMed NHK TBS European Thyroid Journal Nature, Lancet msv ICRP msv msv msv WHO COE sirna M M M VS VS VS
- 16 M7.3 14 M6.5 - - - - - A-4 A-5 A-3 F-3 F-1 C-3 G-1,E-6 C-2 D-1 F-2 E-7 J-1 J-3 B-3 K-1 B-3 I-4 I-3 I-2 I-6 C-1 I-5 B-5 B-2 J-2 A-1 A-2 E-1 B-4 I-1 E-2 E-5 B-1,E-4 E-3 A-1 A-2 A-2 A-3 A-4 A-5 A-2
Rinku General Medical Center
Rinku General Medical Center 4860 100 1620 Ann Intern Med. 1966; 64: 328 40 CHOP 63 1 83 J Clin Oncol. 1998; 16: 20065-69 Febrile Neutropenia IDSA(Infectious Diseases Society of America) 2002 Guidelines
食道がん化学放射線療法後のsalvage手術
2006 2 17 52 Daly JM, et al. J Am Coll Surg 2000;190:562-573 Esophageal Cancer: Results of an American College of Surgeons Patient Care Evaluation Study Daly JM, et al. J Am Coll Surg 2000;190:562-573
untitled
[] 2007 3 2 Hodgkin Plasma cell dysclasia Atrial myxoma with emboli histiocytosis multicentric reticulohistiocytosis Schuller-Christian Gaucher Weber-Christian 1.SLE 2. Gottron Gottron 3. sclerodactyly
16 23 270 5 1 2 3 1 2 3 1 2 3 6 5 54 44 9 9 4,000 118 7 5 JA 8 1 1 2 16 48,000 1 1 1 1 2 2 3 1, 312. 87 4 5 10 3 31 6 10 4 25 7 3 1 2 8 2 495. 84 1 296. 49 2 199. 35 1 124. 62 54. 50 28. 80 34. 17 54.
…_…C…L…fi…J…o†[fiü“ePDF/−mflF™ƒ
80 80 80 3 3 5 8 10 12 14 14 17 22 24 27 33 35 35 37 38 41 43 46 47 50 50 52 54 56 56 59 62 65 67 71 74 74 76 80 83 83 84 87 91 91 92 95 96 98 98 101 104 107 107 109 110 111 111 113 115
エンジョイ北スポーツ
2772083130 83 1 2 3 4 5 6 7 8 2 2 2 3 3 4 4 6 7 8 1211 53 /15,171 /509 /670 /13,992 2 83130 http://www.kita-city-taikyo.or.jp 83130 http://www.kita-city-taikyo.or.jp 3 68 35 45 4 83130 http://www.kita-city-taikyo.or.jp
顔面神経麻痺を来したMPO―ANCA 陽性の中耳炎２症例
11367 : MPOANCA MPO ANCA MPOANCA 134EU MPO ANCA 67EU MPOANCA ANCA : MPOANCAANCA antineutrophil cytoplasmic antibody ; ANCA Davies IgG ANCA PR3proteinase3ANCA MPOmyeloperoxidaseANCA Wegener PR3ANCA MPO
特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書（案）
VOL.51 NO.6 JUNE 2003 JUNE 2003 9) Niederman MS et al: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention.
2 W.T T.S. 70 2 1 238 WBC7400/µl, RBC 386 10 4 /µl, Hb 11.6 g/dl, Ht 36.2%, PLT 25 10 4 /µl AST 19 IU/l, ALT 11 IU/l, LDH 182 IU/l, BUN 15 mg/dl, Cr 0.54 mg/dl, CRP6.83 mg/dl, RF 353.9IU/ml, CCP 28.0IU/ml
2012 Vol. 23 No pseudothrombophlebitis pseudothrombophlebitis
pseudothrombophlebitis 5 424 163 38.1 26 6.1 5 1.2 230 2 3 66.4 51 80 2 3 2 2 1 2012 23 3 261-265 pseudothrombophlebitis 1 2011 7 11 30 2010 2 5 47 Fig. 1 Ultrasonography showed a low echoic cyst in the
動くレントゲン
FPD 1985 1998 2000 2002 FPD X X X FPD X CAD X FPD X CAD X X 1970 Autofluoroscope Toffolo RR, et al. The autofluoroscope and 133-Xe in dynamic studies of pulmonary perfusion and ventilation. Radiology,
w 1 h
9 No.467 SEP. 200214 w 1 h e NEWS NEWS Y r Y t y Y u 1 bf 1 i o !0 d f e Y 1 1 a c 1 !1 7 7 1 !2 e Y 1 de f 1 1 1 !3 1 1 b 71 Y Y Y Y !4 ga Y 7 7 1 E F E A Y u u u u u u u u u u u u u u u u u u u u u u
164 SDD & SOD SDD E100 mg 80 mg B500 mg 2 E 2 B 48 /59 81 SDD SOD 10 /63 16 RCT RCT 1992 Gastinne 15 ICU 445 SDD E100 mg 80 mg B 10
163 特 集 SDD & SOD SDD(Selective digestive decontamination),sod(selective oropharynx decontamination), 腸内細菌叢, 耐性菌 Ⅰ はじめに SDD Selective digestive decontamination SOD Selective oropharynx decontamination
00 p01-24
Feb-Mar Special 3 2 1 P.4 2 P.11 3 P.16 1 100m 100 400m JOC 100 4 Sportsmedicine 2011 NO.128 Sportsmedicine 2011 NO.128 5 10 P.11 1980 70 MRI MRI 1 2 6 30 11 3040 50 10 10 71 67 25 Sportsmedicine 2011
20 15 14.6 15.3 14.9 15.7 16.0 15.7 13.4 14.5 13.7 14.2 10 10 13 16 19 22 1 70,000 60,000 50,000 40,000 30,000 20,000 10,000 0 2,500 59,862 56,384 2,000 42,662 44,211 40,639 37,323 1,500 33,408 34,472
- 2 -
- 2 - - 3 - (1) (2) (3) (1) - 4 - ~ - 5 - (2) - 6 - (1) (1) - 7 - - 8 - (i) (ii) (iii) (ii) (iii) (ii) 10 - 9 - (3) - 10 - (3) - 11 - - 12 - (1) - 13 - - 14 - (2) - 15 - - 16 - (3) - 17 - - 18 - (4) -
2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4 4 4 2 5 5 2 4 4 4 0 3 3 0 9 10 10 9 1 1
1 1979 6 24 3 4 4 4 4 3 4 4 2 3 4 4 6 0 0 6 2 4 4 4 3 0 0 3 3 3 4 3 2 4 3? 4 3 4 3 4 4 4 4 3 3 4 4 4 4 2 1 1 2 15 4 4 15 0 1 2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4
I? 3 1 3 1.1?................................. 3 1.2?............................... 3 1.3!................................... 3 2 4 2.1........................................ 4 2.2.......................................
1 (1) (2)
1 2 (1) (2) (3) 3-78 - 1 (1) (2) - 79 - i) ii) iii) (3) (4) (5) (6) - 80 - (7) (8) (9) (10) 2 (1) (2) (3) (4) i) - 81 - ii) (a) (b) 3 (1) (2) - 82 - - 83 - - 84 - - 85 - - 86 - (1) (2) (3) (4) (5) (6)
橡
TP T-13i AST ALT ALP Y CTP LOH CHE CRP 8.7 id 0.4 mg/d 21 AWL 131U/L 257 LU/L 12 111/L 234 11J/L 344 IU/L 0.30 mid No K a BUN ORE UA 142 meq/1 4.3 meqa 108 meqa 15.8 met! 0.71 mg/di 5.0 mg/d CEA 5_5 n8/m1
Oxford Partial Knee 手技書
Oxford Partial Knee Surgical Technique Oxford Partial Knee The Oxford Partial Knee 1976 1 Phase Phase 24 6 Oxford Partial Knee 1982 4,5 6 Oxford 10 98 5,7 20 92 9 0.03mm 2,3 ArCom UHMWPE 8,9 4 4 XS 3mm7mmSML
1. MAS 1 MAS 2 2. 11 4582 1 No.6(1999 ) 67-79 ( ) 70 10 (1994 ) 3-20 ( ) 70 11 (1994 ) 3-23 ( ) 70 12 (1994 ) 3-20 2-2 -
1. MAS 1 MAS 2 2. 11 4582 1 No.6(1999 ) 67-79 ( ) 70 10 (1994 ) 3-20 ( ) 70 11 (1994 ) 3-23 ( ) 70 12 (1994 ) 3-20 2-2 - 12 3596 13 2584 2 3 12 1 6241 11 9900 4 1 3 A E 5 A B C D E A B C 5 1 1 3 2002 4
36:378 第 38 回日本脳卒中学会講演シンポジウム 原著 36: , 要旨 TIA 2 t-pa Key words: stroke registry, stroke subtype, onset-visi
36:378 第 38 回日本脳卒中学会講演シンポジウム 原著 36: 378 384, 2014 1 2 要旨 1999 2012 10 31 29 26 80 30 TIA 2 t-pa Key words: stroke registry, stroke subtype, onset-visit time, chronological change はじめに 4 12 23 27 1 Japan
THE JAPANESE JOURNAL OF ANTIBIOTICS 65 2 Apr NTT NTT
Apr. 2012 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 2 121 23 7 7 IDSA 122 24 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 2 Apr. 2012 7 2005 3 10 7 2011 6 2 NTT NTT 2011 6 Apr. 2012 THE JAPANESE JOURNAL OF ANTIBIOTICS
<91E F89F1948E91BDD8B3CFC1835A837E B2E786477>
RA 外来診療の基本とコツ 宮原寿明九州医療センター整形外科 リウマチ科 (2009 年 第 10 回博多リウマチセミナー ) 1. リウマチ患者への対応で注意すべきこと 1) 2005 年リウマチ白書 ( 日本リウマチ友の会 ) によれば RA 患者が不安なこととして 悪化 進行 日常生活動作の低下 薬の副作用や合併症 が三大不安としてあげられている 次いで 経済的な不安 が増加してきており 医療費助成制度の後退や高薬価の新薬の影響によるものと思われる
1 見出し1，12ポ，日本語ゴシック，英語Arial，段落後は6ポの設定です
8. Page1 8. B 1 5) 6) 2099 2370 50 400 mg 19 (1) 1) (a) 78.9% 30/38 4 3 35.7% 5/14 71.4% 10/1485.7% 12/142 1 83.3% 5/63 2 1 1 1 8. Page2 (b) 2099 1897 82.4% 1562/1897 2 84.0% 1298/1545 3 2 80.4% 472/58779.0%
C/NC : committed/noncommitted
C/NC : committed/noncommitted 110 time post-icd implant 1) The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report : Effect of encainaide and flecainide on mortality in a
50-3ガイド10ポ.indd
25 7 乳房専用 PET 診療ガイドライン作成メンバー PET 1 はじめに PET 18 F-2- -2- -D- FDG 14 12 FDG-PET FDG-PET 1) T1b 0.5 cm 1.0 cm T1c 1.0 cm 2.0 cm P=0.003 1.0 cm 2) MRI FDG-PET PET 1 cm FDG FDG 1 対向型乳房専用 PET 装置 2 2 3 6) 2 4
32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ
29 1 31 40 2014 31 Bisphosphonate related osteonecrosis of jaw; BRONJ 2008 4 2012 3 36 98 8 11 19 BRONJ 0 13 2 5 3 1 1 0 BP 4 15 10 5 α-streptococcus 0 BRONJ BRONJ BP I Paget 1 409-3898 1110 2014 1 27
JPD-AMC-Catalog-Dec11.indd
GE Measurement & Control Solutions DPI620 HART - 95% 2 MPa ( 20 bar ) - 95% 10 MPa ( 100 bar ) - 0 +100 MPa ( 0 1000 bar ) 0.0025% rdg + 0.002% FS ( ma ) ( mv V ) HART PC Windows CE USB WiFi IEEE802.11
EVALUATION OF MAGNETIC RESONANCE IMAGING (MRI) IN DIAGNOSIS OF ACOUSTIC NEUROMA-COMPARATIVE STUDY WITH PLAIN X-RAY AND CTS- KIMIHISA NOMURA, M.D., MAK
EVALUATION OF MAGNETIC RESONANCE IMAGING (MRI) IN DIAGNOSIS OF ACOUSTIC NEUROMA-COMPARATIVE STUDY WITH PLAIN X-RAY AND CTS- KIMIHISA NOMURA, M.D., MAKOTO SAKAI, M.D., ATSUSHI SHINKAWA, M.D. and HIROSATO
Resection Arthroplasty for Rheumatoid Forefoot Deformity -A 5-year Follow-up Study - Hiroyuki HATTORI, et al. Department of Orthopedic Surgery, Tokyo
Resection Arthroplasty for Rheumatoid Forefoot Deformity -A 5-year Follow-up Study - Hiroyuki HATTORI, et al. Department of Orthopedic Surgery, Tokyo Metropolitan Ohtsuka Hospital Abstract The results
MY16_R8_DI_ indd
R8 Audi R8 Coupé Data Information Audi R8 Specifications mm 4,426 1,940 1,240 4,426 1,940 1,240 mm 2,650 2,650 : mm 1,638 1,638 : mm 1,599 1,599 kg 1,670 1,630 4WD 4WD cc 5,204 5,204 V 10 DOHC V 10 DOHC
untitled
( ) - 1 - - 2 - 38% 26% A) Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma 124 (J Clin Oncol 7: 126-131, 1989) 124 95 29 II 1 2,000mg/m 2 x 4 8g/m
Web Stamps 96 KJ Stamps Web Vol 8, No 1, 2004
The Journal of the Japan Academy of Nursing Administration and Policies Vol 8, No 1, pp 43 _ 57, 2004 The Literature Review of the Japanese Nurses Job Satisfaction Research Which the Stamps-Ozaki Scale
Bulletin of JSSAC(2014) Vol. 20, No. 2, pp (Received 2013/11/27 Revised 2014/3/27 Accepted 2014/5/26) It is known that some of number puzzles ca
Bulletin of JSSAC(2014) Vol. 20, No. 2, pp. 3-22 (Received 2013/11/27 Revised 2014/3/27 Accepted 2014/5/26) It is known that some of number puzzles can be solved by using Gröbner bases. In this paper,
FAX-760CLT
FAX-760CLT ;; yy 1 f a n l p w s m t v y k u c j 09,. i 09 V X Q ( < N > O P Z R Q: W Y M S T U V 1 2 3 4 2 1 1 2 1 2 j 11 dd e i j i 1 ; 3 oo c o 1 2 3 4 5 6 j12 00 9 i 0 9 i 0 9 i 0 9 i oo
日本皮膚科学会雑誌第121巻第11号
β Clin Rheumatol Arthritis Rheum Am J Cardiol J Rheumatol J Rheumatol Arthritis Rheum Arthritis Rheum Arthritis Rheum Rheumatology Oxford Rheumatology Oxford Br J Dermatol Arch Dermatol Ann Rheum Dis
求人面接資料PPT
Hair Salon TV etc. 250" 250" 200" 200" 150" 150" 100" 100" 50" 50" 0" 0" Nov)13" Dec)13" Jan)14" Feb)14" Mar)14" Apr)14" May)14" Jun)14" Jul)14" Dec)12" Jan)13" Feb)13" Mar)13" Apr)13"
Persona The Personalized Knee Brochure
Persona The Personalized Knee Brochure Welcome to Persona The Personalized Knee Persona Personalized Knee System Personalized Implants Proven Technology Precise Instrumentation Table of Contents Personalized
400 46 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec. 2012 LVFX 100 mg 3 / 7 150 mg 2 / 7 2 2006 2008 9 LVFX PK PD 2009 7 100 mg 1 3 500 mg 1 1 AUC/MIC
Dec. 2012 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 399 45 2012 11 5 LVFX 500 mg 1 1 20 Chlamydia trachomatis C. trachomatismycoplasma genitalium M. genitalium LVFX 1 500 mg 1 1 7 22 22 C. trachomatis 17
EPSON LP-S7500シリーズ 取扱説明書1 セットアップと使い方編
A B K L N N N N A B A N B N N A B D A B A B N N N N N N N N N N N K A B E C D F G N N N A B N N A A K B C D L E L L K F A B G N C N N C D B K E A B F AC N K G A B C H K D F E B G H K I G H L J
Key words: bacterial meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, rapid diagnosis, childhood
Key words: bacterial meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, rapid diagnosis, childhood Fig.1 Distribution of the cases with bacterial meningitis by age and pathogens Chiba
07_学術_荷重位X線撮影法の違いによる_山口様.indd
Arts and Sciences X Radiological assessment of joint space width using different weight-bearing radiographic methods for knee osteoarthritis 1 2 1 3 1 3 1 2 3 Key words: knee, osteoarthritis, radiography,
22 1 (-) AST 82 IU/L ANA 40x (-) ALT 46 IU/L homogeneous+speckled γ-gt 21 IU/L RF (-) 10,280 / μl LD 364 IU/L Anti-RNP Ab (-) 9,230 / μl BUN 11.9 mg/d
31 1 21 26 2016 21 1 1 1 1 1 1 1 2 1 1 3 2 59 1 Gottron CT clinically amyopathic dermatomyositis CADM 20 mm PSL 30 mg/ CyA 75 mg/ 35 1000 mg CT 101 D2a 1 CT PSL 5 mg/ 1 26 20 2, 3 clinically amyopathic
VHDL-AMS Department of Electrical Engineering, Doshisha University, Tatara, Kyotanabe, Kyoto, Japan TOYOTA Motor Corporation, Susono, Shizuok
VHDL-AMS 1-3 1200 Department of Electrical Engineering, Doshisha University, Tatara, Kyotanabe, Kyoto, Japan TOYOTA Motor Corporation, Susono, Shizuoka, Japan E-mail: tkato@mail.doshisha.ac.jp E-mail:
2007/8 Vol. J90 D No. 8 Stauffer [7] 2 2 I 1 I 2 2 (I 1(x),I 2(x)) 2 [13] I 2 = CI 1 (C >0) (I 1,I 2) (I 1,I 2) Field Monitoring Server
![2007/8 Vol. J90 D No. 8 Stauffer [7] 2 2 I 1 I 2 2 (I 1(x),I 2(x)) 2 [13] I 2 = CI 1 (C >0) (I 1,I 2) (I 1,I 2) Field Monitoring Server](/thumbs/91/107223763.jpg "2007/8 Vol. J90 D No. 8 Stauffer [7] 2 2 I 1 I 2 2 (I 1(x),I 2(x)) 2 [13] I 2 = CI 1 (C >0) (I 1,I 2) (I 1,I 2) Field Monitoring Server")
a) Change Detection Using Joint Intensity Histogram Yasuyo KITA a) 2 (0 255) (I 1 (x),i 2 (x)) I 2 = CI 1 (C>0) (I 1,I 2 ) (I 1,I 2 ) 2 1. [1] 2 [2] [3] [5] [6] [8] Intelligent Systems Research Institute,
/ / A/ B 16/17 COPD 18mcg COPD COPD COPD 1
11 1 -------------------- 19 205.117/205.128 14/15 205.126A/205.126B 16/17 COPD 18mcg COPD 11.1 11.1.1 COPD 100 19 205.227 COPD 1 FEV1.0 %FEV1.0 70% 1 FEV1.0 / FVC 70% 2 1 200 3 40 COPD 1 10mg ACE 1 1
.g...N...|.[.g25
20039 NPO NPO 20039 NPO 3 2006 91 83 84 1 NPO 1 85 495,800 105 2 200412 2004 1,550 841 200530 20042005 13.4NPO 5.2 393 44334 151 2005:11 1 n=841 2004 86 2005 1 2 7 75.0 4 2 n=17 2005 75.0 37.5 25.0 18.8
図 1 緩和ケアチーム情報共有データベースの患者情報画面 1 患者氏名, 生年月日, 性別, 緩和ケアチームへの依頼内容について,2 入退院記録, 3カンファレンス ラウンド実施一覧,4 問題点のリスト,5 介入内容の記録. 図 2 緩和ケアチームカンファレンス ラウンドによる患者評価入力画面 (
2015; 10(2): 901 5 活動報告 緩和ケアチームデータベースの改良に向けた取り組み 渡邊裕之 1,4), 江藤美和子 2,4) 3,4), 山﨑圭一 1 2 3 4 受付日 2014 年 9 月 10 日 / 改訂日 2015 年 1 月 29 日 / 受理日 2015 年 2 月 3 日 2011 年に, ベルランド総合病院緩和ケアチーム ( 以下,PCT) で構築した PCT 情報共有データベース
udc-2.dvi
13 0.5 2 0.5 2 1 15 2001 16 2009 12 18 14 No.39, 2010 8 2009b 2009a Web Web Q&A 2006 2007a20082009 2007b200720082009 20072008 2009 2009 15 1 2 2 2.1 18 21 1 4 2 3 1(a) 1(b) 1(c) 1(d) 1) 18 16 17 21 10
感覚系における人工臓器 ─人工網膜
人工臓器 最近の進歩 Hiroyuki KANDA, Takashi FUJIKADO 1. はじめに 2. 視覚のなり立ち 図 1 10 著者連絡先 565-0871 2-2 E-mail. kanda@sensory.med.osaka-u.ac.jp 1 3. 視覚障害 Quality of Life QOL 2 1 1 12 18 1 25.5 2 21.0 3 8.8 1) 1 51 New
EAMS 2014
2014 2 10 RCT EAMS 2014 2015. 3. 31 Evidence Reports of Anma-Massage-Shiatsu: 2 Meta-Analisys and 10 Randomized Controlled Trials of Japan 31 Mar 2015 CONTENTS 1. (prologue).. 1 2. (steps for development
cm H.11.3 P.13 2 3-106-
H11.3 H.11.3 P.4-105- cm H.11.3 P.13 2 3-106- 2 H.11.3 P.47 H.11.3 P.27 i vl1 vl2-107- 3 h vl l1 l2 1 2 0 ii H.11.3 P.49 2 iii i 2 vl1 vl2-108- H.11.3 P.50 ii 2 H.11.3 P.52 cm -109- H.11.3 P.44 S S H.11.3
スライド 1
1 2006 msv 2 2011 3 CT 2011 10mSv 10 40mSv 4 2012 217mSv 5 (CT) 2012 50 60mSv 6 2012 510mSv BRCA25 310 10mSv3% BRCA60-280% 3 5m Sv 1m Sv 12% . http://www.rea.or.jp/ire/pdf/report4.pdf 1.10 20 SMR 1.00
2001 Mg-Zn-Y LPSO(Long Period Stacking Order) Mg,,,. LPSO ( ), Mg, Zn,Y. Mg Zn, Y fcc( ) L1 2. LPSO Mg,., Mg L1 2, Zn,Y,, Y.,, Zn, Y Mg. Zn,Y., 926, 1
Mg-LPSO 2566 2016 3 2001 Mg-Zn-Y LPSO(Long Period Stacking Order) Mg,,,. LPSO ( ), Mg, Zn,Y. Mg Zn, Y fcc( ) L1 2. LPSO Mg,., Mg L1 2, Zn,Y,, Y.,, Zn, Y Mg. Zn,Y., 926, 1 1,.,,., 1 C 8, 2 A 9.., Zn,Y,.
a n a n ( ) (1) a m a n = a m+n (2) (a m ) n = a mn (3) (ab) n = a n b n (4) a m a n = a m n ( m > n ) m n 4 ( ) 552
3 3.0 a n a n ( ) () a m a n = a m+n () (a m ) n = a mn (3) (ab) n = a n b n (4) a m a n = a m n ( m > n ) m n 4 ( ) 55 3. (n ) a n n a n a n 3 4 = 8 8 3 ( 3) 4 = 8 3 8 ( ) ( ) 3 = 8 8 ( ) 3 n n 4 n n
28 1 1a 1b 2 MRI T2 3 CT C3 N95 N95 6ml 90
2015 28 1 89 93 CT C3 Tb PCR XP WBC 7 600/mm 3 CRP 4 08mg/dl MRI MRI CT MRI WBC 9 700/mm 3 CRP 6 09mg/dl CT C3 C2 C7 low density area CT 89 28 1 1a 1b 2 MRI T2 3 CT C3 N95 N95 6ml 90 28 1 4 CT C2 C7 low
1) i) Barber, M. et al.: Brit. Med J, 2, 565, 19'49. ii) Barber, M.F.G. J. Hayhoe and J. E. M. Whithead: Lancet, 1120 `1125, 1949.-2) Bergey: Bergey's Manual of Determinative Bacteriology 7 th Ed: (1958).-3)
untitled
47-54 2012 1 1 1 1 1 2 1 2 10 59 1 2 1 5 2 5 10 2 10 4 484 113 42 14 4 Key words Rheumatoid Arthritis Property of the Pain Daily Life Treatment Approaches Process of Acceptance Received June 23, 2011;
終末期癌患者に対する 輸液治療の是非
3 A B NSAID D Case stories A B NSAID D Case stories A. IASP Task Force on Taxonomy WHO Collaborating Center for Palliative Cancer Care : Looking forward to cancer pain relief for all. CBC Oxford, Oxford,
Single slice helical CT CT 1 2005 1 4 1. CT Anti-Lung Cancer Association: ALCA 1-5) 1993 9 10 ALCA (Nawa 6) ) single slice helical CT 10mm CT 2. 1 (http://www.thoracic-ctscreening.org/jpn/index.html )